JNJ-18038683
http://dbpedia.org/resource/JNJ-18038683 an entity of type: Thing
JNJ-18038683 is a potent and selective antagonist of the 5HT7 serotonin receptor discovered by Johnson & Johnson. It has nootropic and antidepressant effects in both animal and human studies and has progressed to Phase II trials as an adjunctive treatment for improving cognition and mood in stable bipolar disorder; it has been found to reduce REM sleep (the lightest stage of sleep, elevated in depression) in humans and block circadian rhythm phase-shift advances in mice.
rdf:langString
rdf:langString
JNJ-18038683
xsd:integer
65285951
xsd:integer
1105900327
xsd:integer
20
xsd:integer
851373
xsd:integer
9327007
xsd:integer
1
xsd:integer
20
xsd:integer
1
xsd:integer
3
xsd:integer
11151899
rdf:langString
C1CNCCC2=C1CC4=CC=CCl
xsd:integer
1
rdf:langString
UKJPMZGILXATGT-UHFFFAOYSA-N
xsd:integer
28
xsd:integer
200
rdf:langString
JNJ-18038683 is a potent and selective antagonist of the 5HT7 serotonin receptor discovered by Johnson & Johnson. It has nootropic and antidepressant effects in both animal and human studies and has progressed to Phase II trials as an adjunctive treatment for improving cognition and mood in stable bipolar disorder; it has been found to reduce REM sleep (the lightest stage of sleep, elevated in depression) in humans and block circadian rhythm phase-shift advances in mice. It binds to the 5-HT6 serotonin receptor with 10x less affinity. At relevant doses, inhibition of 5-HT6 would be expected to render pro-cognitive and anti-dementia effects.
xsd:nonNegativeInteger
4519
xsd:string
851373-91-6
xsd:string
28PGH5X4OQ
xsd:string
11151899